AVROBIO Ownership | Who Owns AVROBIO?
AVROBIO Ownership Summary
AVROBIO is owned by 66.67% institutional investors, and 33.33% retail investors. National bank of canada /fi/ is the largest institutional shareholder, holding 0% of AVRO shares. Bridgeway Ultra-Small Company is the top mutual fund, with 0.08% of its assets in AVROBIO shares.
AVRO Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | AVROBIO | 66.67% | - | 33.33% |
Sector | Healthcare Stocks | 47.06% | 8.01% | 44.93% |
Industry | Biotech Stocks | 44.97% | 7.82% | 47.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
National bank of canada /fi/ | - | - | - |
Renaissance | - | - | - |
Blackrock | - | - | - |
Two sigma advisers, lp | - | - | - |
Tower research capital llc (trc) | - | - | - |
Two sigma securities | - | - | - |
Barclays | - | - | - |
Exome asset management | - | - | - |
Susquehanna group, llp | - | - | - |
Geode capital management | - | - | - |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
National bank of canada /fi/ | - | - | - |
Renaissance | - | - | - |
Blackrock | - | - | - |
Two sigma advisers, lp | - | - | - |
Tower research capital llc (trc) | - | - | - |
Two sigma securities | - | - | - |
Barclays | - | - | - |
Exome asset management | - | - | - |
Susquehanna group, llp | - | - | - |
Geode capital management | - | - | - |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Bank of america corp /de/ | - | - | -2.00 |
Group one trading | - | - | -13.00 |
Citadel advisors | - | - | -100.00 |
Jpmorgan chase | - | - | -282.00 |
National bank of canada /fi/ | - | - | -380.00 |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Atlas venture life science advisors | - | - | -4.54M |
Bml capital management | - | - | -4.00M |
Adar1 capital management | - | - | -3.95M |
Fmr | - | - | -2.02M |
Verition fund management | - | - | -1.93M |
Sold Out
Holder | Change |
---|---|
Bank of america corp /de/ | -2.00 |
Group one trading | -13.00 |
Citadel advisors | -100.00 |
Jpmorgan chase | -282.00 |
National bank of canada /fi/ | -380.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2024 | 49 | 4.26% | 29,554,022 | 24.80% | 66 | 2.36% | 18 | - | 15 | 25.00% |
Dec 31, 2023 | 47 | -6.00% | 23,681,941 | -8.51% | 53 | 1.55% | 18 | -30.77% | 12 | -7.69% |
Sep 30, 2023 | 50 | 19.05% | 25,883,752 | 29.34% | 58 | 2.84% | 26 | 85.71% | 13 | 18.18% |
Jun 30, 2023 | 42 | -14.29% | 20,012,317 | -12.39% | 45 | 1.69% | 14 | -39.13% | 11 | - |
Mar 31, 2023 | 49 | 4.26% | 22,843,401 | 9.94% | 51 | 2.30% | 23 | 91.67% | 11 | -31.25% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Bridgeway Ultra-Small Company | 141.40K | 0.08% | - |
Bridgeway Ultra-Small Company Market | 115.99K | 0.07% | 27.40K |
NT Ext Equity Mkt Idx Fd - NL | 30.97K | 0.02% | - |
Fidelity Nasdaq Composite Index | 27.97K | 0.02% | - |
SSgA U.S. Extended Market Index Class I | 14.90K | 0.01% | - |
Blackstone Alternative Multi-Strategy I | 5.40K | 0.00% | -300.00 |
NT US Market Cap Idx Fd - L | 1.79K | 0.00% | -1.27K |
NT Ext Eq Mkt Indx Fd DC Lending Tier 5 | 1.24K | 0.00% | 240.00 |
JHVIT Total Stock Market Index I | 384.00 | 0.00% | - |
Guggenheim Active Allocation Fund | 225.00 | 0.00% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
May 14, 2024 | Leonard Braden Michael | - | Buy | $385.95K |
May 13, 2024 | Leonard Braden Michael | - | Buy | $272.23K |
May 13, 2024 | Leonard Braden Michael | - | Buy | $313.32K |
Jul 07, 2021 | Vickers Philip J. | - | Buy | $40.08K |
Feb 17, 2021 | Donenberg Phillip B. | - | Buy | $23.42K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q2 | 3 | - |
2024 Q1 | - | - |
2023 Q3 | - | - |
2023 Q2 | - | - |
2023 Q1 | - | - |
AVRO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools